Explore more publications!
STEM Times Cayman Islands
Got News to Share?

STEM Times Cayman Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times Cayman Islands.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 9, 2026

NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit
Apr. 9, 2026

NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit

Indeterminate GlobeNewswire
AirJoule Technologies Named "Water Tech Innovation of the Year" in 2026 CleanTech Breakthrough Awards Program
Apr. 9, 2026

AirJoule Technologies Named "Water Tech Innovation of the Year" in 2026 CleanTech Breakthrough Awards Program

Indeterminate GlobeNewswire
Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer
Apr. 9, 2026

Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer

Indeterminate GlobeNewswire
SAFE, ORION, ARTEMIS And The Army Aviation Association of America (AAAA) - April 15-17, 2026
Apr. 9, 2026

SAFE, ORION, ARTEMIS And The Army Aviation Association of America (AAAA) - April 15-17, 2026

Indeterminate GlobeNewswire
Cloudbreak Pharma Announces Launch of Cloudbreakpharma.com to Raise Awareness of its Pipeline of Novel First-in-Class Therapeutics to Treat Serious Underserved Ophthalmic Diseases
Apr. 9, 2026

Cloudbreak Pharma Announces Launch of Cloudbreakpharma.com to Raise Awareness of its Pipeline of Novel First-in-Class Therapeutics to Treat Serious Underserved Ophthalmic Diseases

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026
Apr. 9, 2026

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

Indeterminate GlobeNewswire
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
Apr. 9, 2026

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%

Indeterminate GlobeNewswire
Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting
Apr. 9, 2026

Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting

Indeterminate GlobeNewswire
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
Apr. 9, 2026

Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026

Indeterminate GlobeNewswire
Trident Digital Tech Partners with Israel’s Cybersecurity Leading Firm Memcyco to Launch Asia-Pacific’s First Preemptive AI Fraud Defense
Apr. 9, 2026

Trident Digital Tech Partners with Israel’s Cybersecurity Leading Firm Memcyco to Launch Asia-Pacific’s First Preemptive AI Fraud Defense

Indeterminate GlobeNewswire
Byrna Technologies Reports Fiscal First Quarter 2026 Results
Apr. 9, 2026

Byrna Technologies Reports Fiscal First Quarter 2026 Results

Indeterminate GlobeNewswire
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
Apr. 9, 2026

Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026

Indeterminate GlobeNewswire
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event
Apr. 9, 2026

AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event

Indeterminate GlobeNewswire
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026
Apr. 9, 2026

Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026

Indeterminate GlobeNewswire
Valitor to Participate in the 25th Annual Needham Virtual Healthcare Conference
Apr. 9, 2026

Valitor to Participate in the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Liner launches Figure Generator on Liner Scholar, expanding AI-powered research from citation to visualization
Apr. 9, 2026

Liner launches Figure Generator on Liner Scholar, expanding AI-powered research from citation to visualization

Indeterminate GlobeNewswire
Mitesco, Inc. Announces Launch of Video Highlighting Strategic Partner Sportzfolio Platform
Apr. 9, 2026

Mitesco, Inc. Announces Launch of Video Highlighting Strategic Partner Sportzfolio Platform

Indeterminate GlobeNewswire
Aduro Awards Permitting Contract to Ebert HERA for FOAK Industrial Project at Chemelot
Apr. 9, 2026

Aduro Awards Permitting Contract to Ebert HERA for FOAK Industrial Project at Chemelot

Indeterminate GlobeNewswire
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples
Apr. 9, 2026

Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

Indeterminate GlobeNewswire
2026 CleanTech Breakthrough Awards Program Honors Companies Powering the Future of Sustainable Innovation
Apr. 9, 2026

2026 CleanTech Breakthrough Awards Program Honors Companies Powering the Future of Sustainable Innovation

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions